瘢痕子宫再次妊娠临床分析

来源 :中国实用医药 | 被引量 : 0次 | 上传用户:fwj108580853
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的探讨瘢痕子宫再次妊娠分娩方式的选择。方法回顾分析80例患者的临床资料。结果本组80例中,自然临产经阴道正常分娩共38例,均有阴道分娩史。Apgar评分均高于6分。1例产后宫缩乏力出血约700 ml,对症状处理后好转,无1例发生子宫破裂。本次病例中瘢痕子宫再次妊娠的阴道分娩率为48%。孕期为38~41周,新生儿体重2700~3850 g。结论瘢痕子宫再妊娠者,不可随意扩大剖宫产指征,对无明确剖宫产指征者,应给予以充分试产,试产过程严密监护,发现异常,及时剖宫产,以降低母婴并发症及剖宫产率。临床应严格判定阴道试产适应证和禁忌证,试产过程中严密观察产程,在技术和设备完善的条件下确保试产安全,使产妇能够顺利经阴道分娩,减少患者的痛苦。 Objective To investigate the choice of delivery mode of scar pregnancy after uterine pregnancy. Methods The clinical data of 80 patients were retrospectively analyzed. Results 80 cases of this group, the natural vaginal delivery of natural abortion a total of 38 cases, have vaginal delivery history. Apgar scores were higher than 6 points. 1 case of postpartum uterine inertia bleeding about 700 ml, the symptoms improved after treatment, no case of uterine rupture occurred. The uterus in this case of pregnancy again vaginal vaginal delivery rate of 48%. Pregnancy for 38 to 41 weeks, neonatal weight 2700 ~ 3850 g. Conclusions Patients with uterine scar pregnancy should not be free to expand indications of cesarean section. For those who have no indication of cesarean section, adequate trial production should be given and the trial production should be closely monitored. Abnormalities should be found and cesarean section should be promptly performed to reduce the risk of cesarean section Infant complications and cesarean section rate. Clinical trial should strictly determine vaginal trial indications and contraindications, trial production process closely observe the labor process, under the conditions of technology and equipment to ensure trial production safety, so that women can successfully vaginal delivery, reduce patient pain.
其他文献
OBJECTIVE To investigate the optimized time period for detection and characterization of renal cell carcinomas (RCC) when the specific CT features appear during
OBJECTIVE To explore the effects of 12-O-tetradecanoylphorbol-13-acetate (TPA) on differentiation, apoptosis and related molecular mechanisms in U937 myelomonoc
期刊
期刊
期刊
期刊
期刊
OBJECTIVE The change of cell immune function after hepatectomy of patients suffering from hepatocellular carcinoma (HCC) is usually neglected. The aim of this s
期刊
期刊